Use of everted sacs of mouse small intestine as enzyme sources for the study of drug oxidation activities in vitro

被引:22
作者
Emoto, C
Yamazaki, H
Yamasaki, S
Shimada, N
Nakajima, M
Yokoi, T [1 ]
机构
[1] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9200934, Japan
[2] Daiichi Pure Chem, Tsukuba, Ibaraki 3191182, Japan
关键词
D O I
10.1080/00498250050200122
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The use of everted sacs of the small intestine as an enzyme source for the study of the first-pass metabolism of xenobiotics by cytochrome P450s (P450, CYP) is described. Several drug oxidation activities for testosterone, chlorzoxazone, tolbutamide, bufuralol and warfarin were observed when everted sacs (1-cm segment) from different parts of mouse small intestine were incubated with an NXDPH-generating system and each substrate. 2. Most of the drug hydroxylase activities resided in the upper part of mouse small intestine and these activities were much higher than those of intestinal microsomes. Drug oxidation activities decreased along the distance from the upper part of the small intestine except for warfarin hydroxylation. 3. Testosterone 6 beta -hydroxylation in the everted sacs exhibited the highest catalytic activities among the drug oxidations tested here. In the upper part of the small intestine, the testosterone 6 beta -hydroxylase activities of everted sacs subjected once to freezing and thawing were substantially decreased compared with the untreated everted sacs. 4. Testosterone 6 beta -hydroxylase activities in the everted sacs of the small intestine were significantly inhibited by ketoconazole. Immunoreactive proteins using anti-CYP3A antibodies were detected in the upper and middle parts of the small intestine. 5. The results demonstrated that the upper part of the mouse small intestine serves as the major site for intestinal P450 mediated first-pass metabolism. Everted sacs of the small intestine are therefore useful for the study of drug metabolism as well as of transport and absorption.
引用
收藏
页码:971 / 982
页数:12
相关论文
共 35 条
[1]   Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions [J].
Bertz, RJ ;
Granneman, GR .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :210-258
[2]   EXPRESSION OF A HUMAN-LIVER CYTOCHROME-P-450 PROTEIN WITH TOLBUTAMIDE HYDROXYLASE-ACTIVITY IN SACCHAROMYCES-CEREVISIAE [J].
BRIAN, WR ;
SRIVASTAVA, PK ;
UMBENHAUER, DR ;
LLOYD, RS ;
GUENGERICH, FP .
BIOCHEMISTRY, 1989, 28 (12) :4993-4999
[3]  
Guengerich FP, 1995, CYTOCHROME P, P473
[4]   Cytochrome P-450 3A4: Regulation and role in drug metabolism [J].
Guengrich, FP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :1-17
[5]  
Hansen T, 2000, XENOBIOTICA, V30, P27
[6]   Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats [J].
Hashimoto, Y ;
Sasa, H ;
Shimomura, M ;
Inui, K .
PHARMACEUTICAL RESEARCH, 1998, 15 (10) :1609-1613
[7]   RADIOLABELING OF METHYLPHOSPHONATE AND PHOSPHOROTHIOATE OLIGONUCLEOTIDES AND EVALUATION OF THEIR TRANSPORT IN EVERTED RAT JEJUNUM SACS [J].
HUGHES, JA ;
AVRUTSKAYA, AV ;
BROUWER, KLR ;
WICKSTROM, E ;
JULIANO, RL .
PHARMACEUTICAL RESEARCH, 1995, 12 (06) :817-824
[8]   Metabolism of rifabutin in human enterocyte and liver microsomes: Kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents [J].
Iatsimirskaia, E ;
Tulebaev, S ;
Storozhuk, E ;
Utkin, I ;
Smith, D ;
Gerber, N ;
Koudriakova, T .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (05) :554-562
[9]  
Jacobsen W, 1999, J PHARMACOL EXP THER, V291, P131
[10]   Comparative effects of omeprazole on xenobiotic metabolizing enzymes in the rat and human [J].
Kashfi, K ;
McDougall, CJ ;
Dannenberg, AJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (06) :625-630